In this interview, Dr. Daniel Singer updates us on the new anticoagulants for atrial fibrillation stroke prevention that he presented about at Boston Atrial Fibrillation Symposium. He provided an update on rivaroxaban (Xarelto), apixaban (Eliquis), dabigatran (Pradaxa), and edoxaban, and mentioned that all were better than warfarin (Coumadin) in preventing intracranial bleeding (bleeding in the …
Read More
At Boston Atrial Fibrillation Symposium 2012, Dr. Hugh Calkins, electrophysiologist at Johns Hopkins, presented the new 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation, which will replace the original guidelines that were published in 2007. Instead of simply rewriting sections that have changed, the writing committee, which was made up …
Read More
Dr. John Mandrola, a cardiac electrophysiologist in Louisville, Kentucky, who blogs at Dr. John M, live-blogged the 2012 Boston Atrial Fibrillation Symposium. He has given us permission to reprint his blog posts for the afib community. You will find them here: Recap of Boston Atrial Fibrillation Symposium 2012 – Guest Posts by Dr. John Mandrola …
Read More
StopAfib.org interviews Dr. Sanjiv Narayan of the University of California at San Diego. Find a transcript of the interview, and more on Dr. Narayan and the FIRM trial at: http://www.stopafib.org/newsitem.cfm/NEWSID/379 In this video interview at the American Heart Association Scientific Sessions 2011, Dr. Narayan discussed the high success rate of the FIRM trial of focal …
Read More
StopAfib.org interviews Prof. Gregory Lip, of the University of Birmingham (UK) Find more information on the CHADS2 scoring system, and on Prof. Lip, at: http://www.stopafib.org/newsitem.cfm/NEWSID/369 In this video interview, Dr. Lip discussed the CHA2DS2-VASc tool, which was recently adopted by the European Society of Cardiology Atrial Fibrillation Guidelines for predicting stroke risk in atrial fibrillation. …
Read More
StopAfib.org interviews Dr. John Mandrola of Baptist Hospital East in Louisville, KY. Trancripts and more information on Dr. Mandrola are available at: http://www.stopafib.org/newsitem.cfm/NEWSID/374 In this video interview at the American Heart Association Scientific Sessions 2011, Dr. John Mandrola discussed the poster he presented there about gender-specific results of atrial fibrillation ablation in a private practice …
Read More
StopAfib.org interviews Dr. Elaine Hylek of Boston University. A transcript of this video, as well as additional information about the topics discussed, and Dr. Hylek, can be found at: http://www.stopafib.org/newsitem.cfm/NEWSID/349 In this video interview, Dr. Elaine Hylek of Boston University discusses new anticoagulant drugs for stroke prevention in atrial fibrillation. For many years, warfarin (Coumadin) …
Read More
StopAfib.org interviews Dr. Hugh Calkins, electrophysiologist at Johns Hopkins Hospital. In this video, Dr. Calkins discussed the current effort to update and rewrite the HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation, which was published in 2007. The goal is to present the new guidelines at the Boston Atrial Fibrillation Symposium …
Read More
StopAfib.org interviews Dr. Patrick Ellinor, electrophysiologist at Massachusetts General Hospital. In this video interview, Dr. Ellinor talked about his research as part of a consortium that investigates the correlation between genetics and atrial fibrillation. He discussed how in the past five to seven years, they have learned that a family history of afib can be …
Read More
StopAfib.org interviews Dr. Matthew Reynolds, of the Harvard Clinical Research Institute. In this video interview, Dr. Reynolds talked about his research looking at outcomes and quality of life following catheter ablation. His research analyzed quality of life data that was collected as part of a previously-reported catheter trial, in which catheter ablation was found to …
Read More